Hotel company Hilton (NYSE:HLT) announced better-than-expected revenue in Q2 CY2025, with sales up 6.3% year on year to $3.14 billion. Its non-GAAP profit of $2.20 per share was 7.8% above analysts’ consensus estimates.
A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets.
Hotel company Hilton (NYSE:HLT) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 6.3% year on year to $3.14 billion. Its non-GAAP profit of $2.20 per share was 7.8% above analysts’ consensus estimates.
Over the past six months, Hilton Grand Vacations has been a great trade, beating the S&P 500 by 14.3%. Its stock price has climbed to $48.75, representing a healthy 17.5% increase. This run-up might have investors contemplating their next move.
Shares of timeshare vacation company Hilton Grand Vacations (NYSE:HGV)
jumped 3.1% in the morning session after Mizuho analysts raised their price target on the stock, citing optimism about the company's growth prospects.
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices.
But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Most consumer discretionary businesses succeed or fail based on the broader economy. This sensitive demand profile can cause discretionary stocks to plummet when macro uncertainty enters the fray,
and over the past six months, the industry has shed 4.6%. This performance was disappointing since the S&P 500 climbed 4.5%.
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
